BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hegi F, D'souza M, Azzi M, De Ruysscher D. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis. Clinical Lung Cancer 2018;19:199-212. [DOI: 10.1016/j.cllc.2017.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vo DT, Heinzerling JH, Timmerman RD. Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. Medical Radiology 2022. [DOI: 10.1007/174_2022_318] [Reference Citation Analysis]
2 Strange CD, Shroff GS, Truong MT, Nguyen QN, Vlahos I, Erasmus JJ. Imaging of the post-radiation chest in lung cancer. Clin Radiol 2021:S0009-9260(21)00253-1. [PMID: 34090709 DOI: 10.1016/j.crad.2021.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gao L, Wang X, Yang X, Gu R, Zhu G, Gao X. A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: Determination of clinical target volume with precise radiotherapy. Thorac Cancer 2021;12:1973-82. [PMID: 34028192 DOI: 10.1111/1759-7714.14000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nie X, Rimner A, Li G. Feasibility of MR-guided radiotherapy using beam-eye-view 2D-cine with tumor-volume projection. Phys Med Biol 2021;66:045020. [PMID: 33361569 DOI: 10.1088/1361-6560/abd66a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ferguson JS, Henne E. Bronchoscopically Delivered Thermal Vapor Ablation of Human Lung Lesions. J Bronchology Interv Pulmonol 2019;26:108-13. [PMID: 30048418 DOI: 10.1097/LBR.0000000000000535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Driessen E, Detillon D, Bootsma G, De Ruysscher D, Veen E, Aarts M, Janssen-Heijnen M. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older. J Geriatr Oncol 2019;10:547-54. [PMID: 30876833 DOI: 10.1016/j.jgo.2019.03.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 Shang S, Wang L, Su Y, Li B, Guo M, Zhu Z, Sun X, Yu J. Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer. Future Oncol 2019;15:1593-603. [PMID: 30855987 DOI: 10.2217/fon-2018-0923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol 2019;20:494-503. [PMID: 30770291 DOI: 10.1016/S1470-2045(18)30896-9] [Cited by in Crossref: 240] [Cited by in F6Publishing: 211] [Article Influence: 80.0] [Reference Citation Analysis]